These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36899376)

  • 1. Recall of substandard medicines in Brazil during the period 2010-2018.
    Oliveira CLCG; Machado VF; de Freitas Tavares H; Ribeiro GLM; Arrais PSD
    BMC Health Serv Res; 2023 Mar; 23(1):238. PubMed ID: 36899376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of Medicines in Portugal: A Retrospective Review of Medicine Recalls (2000-2015).
    Machado Reis AT; Berardo BFR; Loureiro R
    PDA J Pharm Sci Technol; 2018; 72(1):44-49. PubMed ID: 29030530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substandard and falsified medical product recalls in Zambia from 2018 to 2021 and implications on the quality surveillance systems.
    Chabalenge B; Jere E; Nanyangwe N; Hikaambo C; Mudenda S; Banda M; Kalungia A; Matafwali S
    J Med Access; 2022; 6():27550834221141767. PubMed ID: 36601496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of medicines: Deficiencies found by Brazilian Health Regulatory Agency (ANVISA) on good manufacturing practices international inspections.
    Geyer ARC; Sousa VD; Silveira D
    PLoS One; 2018; 13(8):e0202084. PubMed ID: 30089162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of medicines in Sri Lanka: a retrospective review of safety alerts.
    Tharmalinga Sharma JJ; Ketharam M; Herath KB; Shobia SS
    BMC Health Serv Res; 2023 Sep; 23(1):980. PubMed ID: 37700302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of medicines in Canada: a retrospective review of risk communication documents (2005-2013).
    Almuzaini T; Sammons H; Choonara I
    BMJ Open; 2014 Oct; 4(10):e006088. PubMed ID: 25361839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substandard drugs: a potential crisis for public health.
    Johnston A; Holt DW
    Br J Clin Pharmacol; 2014 Aug; 78(2):218-43. PubMed ID: 24286459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmenting Product Defect Surveillance Through Web Crawling and Machine Learning in Singapore.
    Ang PS; Teo DCH; Dorajoo SR; Prem Kumar M; Chan YH; Choong CT; Phuah DST; Tan DHM; Tan FM; Huang H; Tan MSH; Ng MSY; Poh JWW
    Drug Saf; 2021 Sep; 44(9):939-948. PubMed ID: 34148223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Quality of over-the-counter medicines: a study with dipyrone brands commercialized in a drugstore in Cascavel city (Paraná, Brazil)].
    Knappmann AL; de Melo EB
    Cien Saude Colet; 2010 Nov; 15 Suppl 3():3467-76. PubMed ID: 21120334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring the manufacturing and quality of medicines: a fundamental task of pharmacovigilance.
    Sardella M; Belcher G; Lungu C; Ignoni T; Camisa M; Stenver DI; Porcelli P; D'Antuono M; Castiglione NG; Adams A; Furlan G; Grisoni I; Hall S; Boga L; Mancini V; Ciuca M; Chonzi D; Edwards B; Mangoni AA; Tuccori M; Prokofyeva E; De Gregorio F; Bertazzoli Grabinski Broglio M; van Leeuwen B; Kruger P; Rausch C; Le Louet H
    Ther Adv Drug Saf; 2021; 12():20420986211038436. PubMed ID: 34394910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cross-sectional analysis of falsified, counterfeit and substandard medicines in a low-middle income country.
    Khurelbat D; Dorj G; Sunderland B; Sanjjav T; Bayarsaikhan E; Damdinjav D; Dorj G; Jigjidsuren A; Lkhagvasuren O; Erdenetsetseg B
    BMC Public Health; 2020 May; 20(1):743. PubMed ID: 32434489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceutical Regulatory Framework in Ethiopia: A Critical Evaluation of Its Legal Basis and Implementation.
    Suleman S; Woliyi A; Woldemichael K; Tushune K; Duchateau L; Degroote A; Vancauwenberghe R; Bracke N; De Spiegeleer B
    Ethiop J Health Sci; 2016 May; 26(3):259-76. PubMed ID: 27358547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Automated Classification of Quality Defect Issues Relating to Substandard Medicines Using a Hybrid Machine Learning and Rule-Based Approach.
    Teo DCH; Huang Y; Dorajoo SR; Ng MSY; Choong CT; Phuah DST; Tan DHM; Tan FM; Huang H; Tan MSH; Koh ST; Poh JWW; Ang PS
    Drug Saf; 2023 Oct; 46(10):975-989. PubMed ID: 37776421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Medicines Recall Announcements in Saudi Arabia Between 2017 and 2022: An Analysis of Saudi Food and Drug Authority (SFDA) Reports.
    Almutairi M; Algabbani A; Alasiri A; Alhomaidan A; Alqahtani AS
    Ther Innov Regul Sci; 2024 Jul; 58(4):689-695. PubMed ID: 38546962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of combined screening methods for rapid detection of falsified and/or substandard medicines in the absence of a confirmatory method.
    Opuni KF; Nettey H; Larbi MA; Amartey SNA; Nti G; Dzidonu A; Owusu-Danso P; Owusu NA; Nyarko AK
    Malar J; 2019 Dec; 18(1):403. PubMed ID: 31805937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substandard and Falsified Medicines: Proposed Methods for Case Finding and Sentinel Surveillance.
    Pisani E; Hasnida A; Rahmi M; Kok MO; Harsono S; Anggriani Y
    JMIR Public Health Surveill; 2021 Aug; 7(8):e29309. PubMed ID: 34181563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using VigiBase to Identify Substandard Medicines: Detection Capacity and Key Prerequisites.
    Juhlin K; Karimi G; Andér M; Camilli S; Dheda M; Har TS; Isahak R; Lee SJ; Vaughan S; Caduff P; Norén GN
    Drug Saf; 2015 Apr; 38(4):373-82. PubMed ID: 25687792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Institutional barriers and enablers to implementing and complying with internationally accepted quality standards in the local pharmaceutical industry of Pakistan: a qualitative study.
    Tauqeer F; Myhr K; Gopinathan U
    Health Policy Plan; 2019 Jul; 34(6):440-449. PubMed ID: 31302684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A QRM Discussion of Microbial Contamination of Non-sterile Drug Products, Using FDA and EMA Warning Letters Recorded between 2008 and 2016.
    Santos AMC; Doria MS; Meirinhos-Soares L; Almeida AJ; Menezes JC
    PDA J Pharm Sci Technol; 2018; 72(1):62-72. PubMed ID: 29242394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.